Drug Patents owned by St Renatus

1. Drug name - KOVANAZE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9308191 ST RENATUS Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration Apr, 2030

(7 years from now)

US8580282 ST RENATUS Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration Apr, 2030

(7 years from now)

Drugs and Companies using OXYMETAZOLINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE ingredient

Treatment: Method of anesthetizing at least a portion of the maxillary dental arch

Dosage: SPRAY, METERED;NASAL

More Information on Dosage
Strength Dosage Availability
0.1MG/SPRAY;6MG/SPRAY SPRAY, METERED;NASAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.